BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 34585848)

  • 1. A homozygous R148W mutation in Semaphorin 7A causes progressive familial intrahepatic cholestasis.
    Pan Q; Luo G; Qu J; Chen S; Zhang X; Zhao N; Ding J; Yang H; Li M; Li L; Cheng Y; Li X; Xie Q; Li Q; Zhou X; Zou H; Fan S; Zou L; Liu W; Deng G; Cai SY; Boyer JL; Chai J
    EMBO Mol Med; 2021 Nov; 13(11):e14563. PubMed ID: 34585848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
    Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation.
    Stieger B
    Handb Exp Pharmacol; 2011; (201):205-59. PubMed ID: 21103971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive familial intrahepatic cholestasis, type 1, is associated with decreased farnesoid X receptor activity.
    Chen F; Ananthanarayanan M; Emre S; Neimark E; Bull LN; Knisely AS; Strautnieks SS; Thompson RJ; Magid MS; Gordon R; Balasubramanian N; Suchy FJ; Shneider BL
    Gastroenterology; 2004 Mar; 126(3):756-64. PubMed ID: 14988830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and localization of hepatobiliary transport proteins in progressive familial intrahepatic cholestasis.
    Keitel V; Burdelski M; Warskulat U; Kühlkamp T; Keppler D; Häussinger D; Kubitz R
    Hepatology; 2005 May; 41(5):1160-72. PubMed ID: 15841457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation within a transmembrane helix of the bile salt export pump (BSEP, ABCB11) with delayed development of cirrhosis.
    Stindt J; Ellinger P; Weissenberger K; Dröge C; Herebian D; Mayatepek E; Homey B; Braun S; Schulte am Esch J; Horacek M; Canbay A; Schmitt L; Häussinger D; Kubitz R
    Liver Int; 2013 Nov; 33(10):1527-35. PubMed ID: 23758865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin 7A interacts with nuclear factor NF-kappa-B p105 via integrin β1 and mediates inflammation.
    Li X; Xie W; Pan Q; Zhang X; Zhang L; Zhao N; Xie Q; Ding J; Chai J
    Cell Commun Signal; 2023 Jan; 21(1):24. PubMed ID: 36717921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geniposidic acid protected against ANIT-induced hepatotoxity and acute intrahepatic cholestasis, due to Fxr-mediated regulation of Bsep and Mrp2.
    Chen H; Huang X; Min J; Li W; Zhang R; Zhao W; Liu C; Yi L; Mi S; Wang N; Wang Q; Zhu C
    J Ethnopharmacol; 2016 Feb; 179():197-207. PubMed ID: 26723467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic cholestasis, causes and consequences for hepatobiliary transport.
    Jansen PL; Sturm E
    Liver Int; 2003 Oct; 23(5):315-22. PubMed ID: 14708891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful mutation-specific chaperone therapy with 4-phenylbutyrate in a child with progressive familial intrahepatic cholestasis type 2.
    Gonzales E; Grosse B; Cassio D; Davit-Spraul A; Fabre M; Jacquemin E
    J Hepatol; 2012 Sep; 57(3):695-8. PubMed ID: 22609309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
    Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
    World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
    Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis.
    Keitel V; Burdelski M; Vojnisek Z; Schmitt L; Häussinger D; Kubitz R
    Hepatology; 2009 Aug; 50(2):510-7. PubMed ID: 19642168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive familial intrahepatic cholestasis: genetic disorders of biliary transporters.
    Harris MJ; Le Couteur DG; Arias IM
    J Gastroenterol Hepatol; 2005 Jun; 20(6):807-17. PubMed ID: 15946126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in familial and congenital cholestatic diseases. Clinical and diagnostic implications.
    Colombo C; Okolicsanyi L; Strazzabosco M
    Dig Liver Dis; 2000 Mar; 32(2):152-9. PubMed ID: 10975791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined mutations of canalicular transporter proteins cause severe intrahepatic cholestasis of pregnancy.
    Keitel V; Vogt C; Häussinger D; Kubitz R
    Gastroenterology; 2006 Aug; 131(2):624-9. PubMed ID: 16890614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted pharmacotherapy in progressive familial intrahepatic cholestasis type 2: Evidence for improvement of cholestasis with 4-phenylbutyrate.
    Gonzales E; Grosse B; Schuller B; Davit-Spraul A; Conti F; Guettier C; Cassio D; Jacquemin E
    Hepatology; 2015 Aug; 62(2):558-66. PubMed ID: 25716872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma.
    Scheimann AO; Strautnieks SS; Knisely AS; Byrne JA; Thompson RJ; Finegold MJ
    J Pediatr; 2007 May; 150(5):556-9. PubMed ID: 17452236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Late-Onset Drug-Induced Cholestasis in a Living-Related Liver Transplant Donor With Progressive Familial Intrahepatic Cholestasis.
    Harmancı Ö; Ensaroğlu F; Özçay F; Öcal S; Korkmaz M; Özdemir BH; Selçuk H; Moray G; Haberal M
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():107-9. PubMed ID: 26640927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.